¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"peripheral visual field"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • visual efficiency
    ½Ã(°¢)È¿À²
  • visual evoked potential
    ½Ã°¢À¯¹ßÀüÀ§
  • visual evoked response
    ½Ã°¢À¯¹ß¹ÝÀÀ
  • visual hallucination
    ȯ½Ã
  • visual image
    ½Ã°¢»ó
  • visual infancy
    ¿µ¾ÆÇü½Ã°¢
  • visual inspection
    ½ÃÁø
  • visual line
    ½Ã(°¢)¼±
  • visual maturity
    ½Ã°¢¼º¼÷µµ
  • visual memory
    ½Ã°¢±â¾ï
  • visual nystagmus
    ½Ã°¢´«¶³¸², ½Ã°¢¾ÈÁø
  • visual organ
    ½Ã°¢±â°ü
  • visual pathway
    ½Ã°¢°æ·Î
  • visual pigment
    ½Ã°¢»ö¼Ò
  • visual projection area
    ½Ã°¢Åõ»ç¿µ¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • visual hallucination
    ȯ½Ã, º¸ÀÓȯ°¢
  • visual image
    ½Ã°¢»ó
  • visual infancy
    ¿µ¾ÆÇü½Ã°¢
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • visual line
    ½Ã°¢¼±
  • visual maturity
    ¼º¼÷½Ã°¢
  • visual memory
    ½Ã°¢±â¾ï
  • visual nystagmus
    ½Ã°¢´«¶³¸²
  • visual organ
    ½Ã°¢±â°ü
  • visual pathway
    ½Ã°¢°æ·Î
  • visual pigment
    ½Ã»ö¼Ò
  • visual purple
    ½Ã»ö¼Ò
  • visual evoked potential
    ½Ã°¢À¯¹ßÀüÀ§
  • visual receptor
    ½Ã°¢¼ö¿ëü, °¨±¤Ã¼
  • visual red
    (¢¡rhodopsin) ½ÃÈ«, ·Îµ½½Å
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • peripheral nerve
    ¸»ÃʽŰæ(ØÇôþãêÌè)
  • peripheral nerve block
    ¸»ÃʽŰæÂ÷´Ü.
  • peripheral nerve stimulator
    ¸»ÃʽŰæÀÚ±ØÀåÄ¡(¡­ô§Ð½íûöÇ).
  • peripheral nerve system
    ¸»ÃʽŰæ°è(¡­Í§).
  • peripheral nerve,axonal degeneration
    Ãà»èº¯¼º(õîÞþܨàõ)
  • peripheral nerve,compression
    ¾Ð¹Ú(äâÚÞ), °¡¾Ð(Ê¥äâ)
  • peripheral nervous system
    ¸»ÃʽŰæ°è
  • peripheral nervous system
    ¸»ÃʽŰæ°èÅë, ¸»ÃʽŰæ°è(ØÇ ãêÌèͧ).
  • peripheral nervous system
    ¸»ÃʽŰæ°èÅë
  • peripheral neuralgia
    ¸»ÃʽŰæÅë(¡­÷Ô).
  • peripheral neurectomy
    ¸»ÃʽŰæÀý´Ü(¼ú)(¡­ôîÓ¨âú).
  • peripheral neuritis
    ¸»ÃʽŰ濰(¡­æú).
  • peripheral neuropathy
    ¸»ÃʽŰ溴Áõ.
  • peripheral neuropathy
    ¸»ÃʽŰ溴Áõ(ØÇôþãêÌèÜ»ñø)
  • peripheral neuropathy,diphtheritic
    µðÇÁÅ׸®¾Æ¼º(¡­àõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • static field inhomogeneity
    Á¤ÀÚÀåºÒ±ÕÁú
  • static magnetic field
    Á¤ÀÚÀå
  • super high field MR scanner
    ÃʰíÀÚÀåMR½ºÄ³³Ê, ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra high field MR scanner
    ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra low field MR scanner
    ÃÊÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • upper lung field
    »óÆó±¸¿ª, »óÆó¾ß
  • vertical field magnet
    ¼öÁ÷ÀÚÀåÀÚ¼®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
VI Roman numeral six; vaginal irrigation; variable interval; vastus intermedius; virgo intacta; virulen...
PVC peripheral venous catheterization; persistent vaginal cornification; polyvinyl chloride; postvoiding...
PAOD peripheral arterial occlusive disease; peripheral arteriosclerotic occlusive disease
PBL peripheral blood leukocyte; peripheral blood lymphocyte; problem-based learning
PBM peak bone mass; peripheral basement membrane; peripheral blood mononuclear [cell]; placental basemen...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
SVV Subjective visual vertical
UCVA Uncorrected visual acuity
VAS Visual Analog Scale
VAPS Visual Analogue Pain Score
VAS Visual Analogue Scale
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • treatment field
    Ä¡·á ¹üÀ§
  • ultra high field MR scanner
    ÃʰíÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • afferent peripheral nerve
    ±¸½É¼º ¸»ÃʽŰæ
  • calcified peripheral fibroma
    ¼®È¸È­ º¯¿¬¼º ¼¶À¯Á¾
  • denervated peripheral region
    Å»½Å°æ ¸»ÃÊ ¿µ¿ª
  • diabetic peripheral neuropathy
    ´ç´¢º´¼º ½Å°æº´Áõ
    ÀÓ»óÀûÀ¸·Î ¿øÀ§ ½Å°æÀ» ´ëμºÀ¸·Î ħ¹üÇϸç ÁÖ·Î °¨°¢¼º ´Ù¹ß ½Å°æº´ÁõÀÇ ÇüŸ¦ ÃëÇÑ´Ù. º´¸®ÇÐÀûÀ¸·Î´Â ÁÖ·Î Ãà»èÀÇ º´º¯À̳ª ºÎÀ§¿¡ µû¶ó Å»¼öÃÊÀÇ Çö»óÀ» º¸À̱⵵ ÇÑ´Ù. ½Å°æ¼¶À¯ ³»¸·ÀÇ ¼¼µ¿¸Æ º®Àº ÃÊÀھ缺 ºñÈĸ¦ º¸ÀÌ¸ç ±âÀú¸·ÀÇ ºñÈĵµ µ¿¹ÝµÇ¾î ÀÖ´Ù. ÀÌ·¯ÇÑ ¸»ÃʽŰ溴ÁõÀÇ ¿øÀÎÀº ºÐ¸íÄ¡ ¾ÊÀ¸³ª Ç÷°ü º¯È­¿¡ ÀÇÇÑ ÇãÇ÷¼º ¼Õ»ó ¶Ç´Â ¼Ò¸£ºñÅç »ó½Â¿¡ ÀÇÇÑ »ýÈ­ÇÐÀû ¼Õ»ó µîÀÌ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù°í ÃßÁ¤µÇ°í ÀÖ´Ù.
  • major peripheral nerve
    ÁÖ¿ä ¸»ÃÊ ½Å°æ
  • paralysis, peripheral vocal cord
    ¸»Ãʼº ¼º´ë ¸¶ºñ
  • peripheral
    ¸»Ãʼº, ¸»ÃʼºÀÇ, ¸»ÃÊ
    ¸»ÃÊ °¡±îÀÌ È¤Àº ¸»ÃÊ¿¡ À§Ä¡ÇÏ´Â ¶Ç´Â ÀÌ¿Í °ü·ÃµÈ. Áß½É È¤Àº Á᫐ ±¸Á¶¿¡¼­ ¸Ö¸® À§Ä¡ÇÏ´Â.
  • peripheral aneurysm
    ¸»ÃÊ µ¿¸Æ·ù
  • peripheral anterior synechia
    ÁÖº¯ ȫä ¾Õ À¯Âø
  • peripheral axon
    ¸»ÃÊ Ãà»è
  • peripheral cataract
    ÁÖº¯ ¹é³»Àå
  • peripheral chemoreceptor
    ¸»ÃÊ È­ÇÐ ¼ö¿ëü
  • peripheral circulation
    ¸»ÃÊ ¼øÈ¯
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
visual-spatial agnosia The inability to localise objects or to appreciate distance, motion, and spatial relationships; caused by lesion in the occipital lobe.
Compare: simultanagnosia.
(05 Mar 2000)
visual threshold Threshold of visual sensation, the minimal light intensity evoking a visual sensation.
Synonym: achromatic threshold, minimum light threshold.
(05 Mar 2000)
visual violet A visual pigment, composed of 11-cis-retinal bound to an opsin, found in the cones of the retina.
Synonym: visual violet.
Origin: G. Ion, violet, + ops, eye, + -in
(05 Mar 2000)
visual yellow The orange retinaldehyde resulting from the action of light on the rhodopsin of the retina, which converts the 11-cis-retinal component of the rhodopsin to all-trans-retinal plus opsin.
Synonym: trans-retinal, visual yellow.
(05 Mar 2000)
primary visual area Area of the occipital lobe concerned with vision.
(12 Dec 1998)
primary visual cortex See: visual cortex.
(05 Mar 2000)
secondary visual area Area of the occipital lobe concerned with vision.
(12 Dec 1998)
secondary visual cortex See: visual cortex.
(05 Mar 2000)
evoked potentials, visual The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways.
(12 Dec 1998)
unformed visual hallucination Hallucination composed of sparks, lights, or bursting spheres of light.
(05 Mar 2000)
formed visual hallucination <psychiatry> Hallucination composed of scenes, often landscapes.
(05 Mar 2000)
functional visual loss An apparent loss of visual acuity or visual field with no substantiating physical signs; often due to a natural concern about visual loss combined with suggestibility and a fear of the worst; best treated with reassurance.
(05 Mar 2000)
auditory field The space included within the limits of hearing of a definite sound, as of a tuning fork.
(05 Mar 2000)
bright field illumination <microscopy> The method of lighting the specimen with a solid cone of rays. Transmitted bright field illumination is performed by a substage condenser. Reflected bright field illumination is performed by a vertical illuminator.
Compare: dark field illumination
(05 Aug 1998)
bright field imaging <microscopy> An imaging mode in a transmission electron microscopy that uses only unscattered Electrons to form the image. Contrast in such an image is due entirely to mass-thickness variations in amorphous samples, and may include diffraction contrast in crystalline samples.
(05 Aug 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • field lark
    =MEADOWLARK
  • field length
    ÀÌÂø·ú ȰÁÖ °Å¸®
  • field lens
    ´ë¹° ·»Áî;½Ã¿ª ·»Áî
  • field line
    ÈûÀÇ ¼±
  • field magnet
    °èÀÚ;ÀåÀÚ¼®
  • field method
    ¾ß¿Ü ¿¬±¸¹ý !
  • field mouse
    µéÁã
  • field music
    ±º¾Ç´ë(±º¾Ç ´ë¿ë)ÇàÁø°î
  • field officer
    À°±ºÀÇ ¿µ°ü±Þ Àå±³
  • field preacher
    ¾ß¿Ü Àüµµ»ç(¼³±³»ç)
  • field punishment
    ÀüÁö Çü¹ú 
  • field ration
    ¾ßÀü¾ç½Ä
  • field recording
    ÇöÁö ³ìÀ½
  • field secretary
    ¿Ü±Ù Á÷¿ø;Áö¹æ ¿¬¶ô¿ø
  • field service
    ¾ßÀü±Ù¹«
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á